NUVASIVE INC Quarterly Common Stock, Shares Authorized from Q2 2010 to Q2 2023

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Nuvasive Inc quarterly Common Stock, Shares Authorized history and growth rate from Q2 2010 to Q2 2023.
  • Nuvasive Inc Common Stock, Shares Authorized for the quarter ending June 30, 2023 was 150M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 150M 0 0% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 150M 0 0% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 150M 0 0% Dec 31, 2022 10-Q 2023-08-02
Q3 2022 150M 0 0% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 150M 0 0% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 150M 0 0% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 150M 0 0% Dec 31, 2021 10-K 2023-02-22
Q3 2021 150M 0 0% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 150M +30M +25% Jun 30, 2021 10-Q 2021-07-28
Q1 2021 150M +30M +25% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 150M +30M +25% Dec 31, 2020 10-K 2022-02-23
Q3 2020 150M +30M +25% Sep 30, 2020 10-Q 2020-10-29
Q2 2020 120M 0 0% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 120M 0 0% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 120M 0 0% Dec 31, 2019 10-K 2021-02-25
Q3 2019 120M 0 0% Sep 30, 2019 10-Q 2019-10-30
Q2 2019 120M 0 0% Jun 30, 2019 10-Q 2019-07-30
Q1 2019 120M 0 0% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 120M 0 0% Dec 31, 2018 10-K 2020-02-20
Q3 2018 120M 0 0% Sep 30, 2018 10-Q 2018-10-30
Q2 2018 120M 0 0% Jun 30, 2018 10-Q 2018-07-31
Q1 2018 120M 0 0% Mar 31, 2018 10-Q 2018-05-01
Q4 2017 120M 0 0% Dec 31, 2017 10-K 2019-02-20
Q3 2017 120M 0 0% Sep 30, 2017 10-Q 2017-10-24
Q2 2017 120M 0 0% Jun 30, 2017 10-Q 2017-07-27
Q1 2017 120M 0 0% Mar 31, 2017 10-Q 2017-04-25
Q4 2016 120M 0 0% Dec 31, 2016 10-K 2018-02-26
Q3 2016 120M 0 0% Sep 30, 2016 10-Q 2016-10-26
Q2 2016 120M 0 0% Jun 30, 2016 10-Q 2016-07-26
Q1 2016 120M 0 0% Mar 31, 2016 10-Q 2016-04-26
Q4 2015 120M 0 0% Dec 31, 2015 10-K 2017-02-09
Q3 2015 120M 0 0% Sep 30, 2015 10-Q 2015-10-27
Q2 2015 120M 0 0% Jun 30, 2015 10-Q 2015-07-28
Q1 2015 120M 0 0% Mar 31, 2015 10-Q 2015-05-04
Q4 2014 120M 0 0% Dec 31, 2014 10-K 2016-02-11
Q3 2014 120M 0 0% Sep 30, 2014 10-Q 2014-10-30
Q2 2014 120M 0 0% Jun 30, 2014 10-Q 2014-07-30
Q1 2014 120M 0 0% Mar 31, 2014 10-Q 2014-04-30
Q4 2013 120M 0 0% Dec 31, 2013 10-K 2015-02-25
Q3 2013 120M 0 0% Sep 30, 2013 10-Q 2013-10-30
Q2 2013 120M 0 0% Jun 30, 2013 10-Q 2013-07-30
Q1 2013 120M 0 0% Mar 31, 2013 10-Q 2013-05-01
Q4 2012 120M +50M +71.4% Dec 31, 2012 10-K 2014-03-03
Q3 2012 120M 0 0% Sep 30, 2012 10-Q 2012-10-25
Q2 2012 120M +50M +71.4% Jun 30, 2012 10-Q 2012-07-26
Q1 2012 120M +50M +71.4% Mar 31, 2012 10-Q 2012-05-01
Q4 2011 70M 0 0% Dec 31, 2011 10-K 2014-03-03
Q3 2011 120M +50M +71.4% Sep 30, 2011 10-Q 2012-10-25
Q2 2011 70M 0 0% Jun 30, 2011 10-K 2014-03-03
Q1 2011 70M Mar 31, 2011 10-Q 2011-05-06
Q4 2010 70M Dec 31, 2010 10-K 2013-02-27
Q3 2010 70M Sep 30, 2010 10-Q 2010-11-05
Q2 2010 70M Jun 30, 2010 10-Q 2010-08-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.